OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling

Pancreatic cancer is an aggressive malignancy that is the fourth leading cause of death worldwide. Since there is a dire need for novel and effective therapies to improve the poor survival rates of advanced pancreatic cancer patients, we analyzed the antitumor effects of OSU-A9, an indole-3-carbinol...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wan-Chi, Bai, Li-Yuan, Chen, Yi-Jin, Chu, Po-Chen, Hsu, Ya-Wen, Sargeant, Aaron M., Weng, Jing-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438726/
https://www.ncbi.nlm.nih.gov/pubmed/28418923
http://dx.doi.org/10.18632/oncotarget.16450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438726/
https://www.ncbi.nlm.nih.gov/pubmed/28418923
http://dx.doi.org/10.18632/oncotarget.16450

Ejemplares similares